Enveric Biosciences Inc vs Trane Technologies plc — how do they compare? Enveric Biosciences Inc trades at $1.2 (market cap $6.27M), while Trane Technologies plc trades at $471.29 (market cap $105.17B). The key difference: Trane Technologies plc is far larger — about 16773.5× Enveric Biosciences Inc's market cap, and Trane Technologies plc pays a 0.88% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | TT | |
|---|---|---|
Market Cap | $6.27M | $105.17B |
Volume | 100,675 | 1,040,183 |
Sector | Health | Industrials |
52-Week High | $10.80 | $503.46 |
52-Week Low | $1.27 | $376.43 |
Typical Hold Time | 14 Days | — |
Enterprise Value | -$2.03M | $108.47B |
Dividend Yield | — | 0.88% |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.40, down 4.76% with a bearish technical signal from moving averages. The company shows negative profitability metrics with ROE at -235.48% and no revenue in 2025, though it has consistently beaten EPS estimates. Recent news highlights patent approvals and positive preclinical data for its neuroplastogenic therapeutics.
The outlook remains speculative given the lack of revenue and negative cash flow from operations. Analyst consensus is 75% buy, but high business execution risks and dependence on drug development success pose significant challenges for near-term shareholder value.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →